TX SB883 | 2025-2026 | 89th Legislature
Status
Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on January 23 2025 - 25% progression
Action: 2025-02-13 - Referred to Health & Human Services
Pending: Senate Health & Human Services Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 23 2025 - 25% progression
Action: 2025-02-13 - Referred to Health & Human Services
Pending: Senate Health & Human Services Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Title
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Sponsors
Sen. Angela Paxton [R] | Sen. Bob Hall [R] |
History
Date | Chamber | Action |
---|---|---|
2025-02-13 | Senate | Referred to Health & Human Services |
2025-02-13 | Senate | Read first time |
2025-01-23 | Senate | Filed |
2025-01-23 | Senate | Received by the Secretary of the Senate |
Subjects
COVID-19
Health
Health Care Providers
Health--General
Health--Other Diseases & Medical Conditions
MEDICAL BOARD, TEXAS
MEDICINE & PRESCRIPTION DRUGS
PHYSICIANS
RIGHT TO TREAT ACT
Health
Health Care Providers
Health--General
Health--Other Diseases & Medical Conditions
MEDICAL BOARD, TEXAS
MEDICINE & PRESCRIPTION DRUGS
PHYSICIANS
RIGHT TO TREAT ACT
Texas State Sources
Type | Source |
---|---|
Summary | https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=SB883 |
Text | https://capitol.texas.gov/tlodocs/89R/billtext/html/SB00883I.htm |